Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Hulse

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Drugs|May 25, 2017
A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed NeonatesErin Kelty, Gary Hulse
Drugs|May 25, 2017
A Retrospective Cohort Study of Obstetric Outcomes in Opioid-Dependent Women Treated with Implant Naltrexone, Oral Methadone or Sublingual Buprenorphine, and Non-Dependent ControlsErin Kelty, Gary Hulse
The American Journal on Addictions|November 17, 2017
A retrospective cohort study of the health of children prenatally exposed to methadone, buprenorphine or naltrexone compared with non-exposed control childrenErin Kelty, Gary Hulse
The International Journal on Drug Policy|June 14, 2017
Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexoneErin Kelty, Gary Hulse
Addiction (Abingdon, England)|April 11, 2012
Examination of mortality rates in a retrospective cohort of patients treated with oral or implant naltrexone for problematic opiate useErin Kelty, Gary Hulse
Journal of Public Health (Oxford, England)|June 8, 2017
Morbidity and mortality in opioid dependent patients after entering an opioid pharmacotherapy compared with a cohort of non-dependent controlsErin Kelty, Gary Hulse
Journal of Psychopharmacology (Oxford, England)|January 11, 2021
Pharmacological uses of flumazenil in benzodiazepine use disorders: a systematic review of limited dataAlexander T Gallo, Gary Hulse
Clinical Trials (London, England)|December 18, 2012
Assessing the usefulness of health data linkage in obtaining adverse event data in a randomised controlled trial of oral and implant naltrexone in the treatment of heroin dependenceErin Kelty, Hanh Ngo, Gary Hulse
The American Journal of Drug and Alcohol Abuse|December 21, 2019
A comparison of blood toxicology in fatalities involving alcohol and other drugs in patients with an opioid use disorder treated with methadone, buprenorphine, and implant naltrexoneErin Kelty, Gary Hulse, David Joyce
The American Journal of Drug and Alcohol Abuse|March 9, 2019
A retrospective cohort study of mortality rates in patients with an opioid use disorder treated with implant naltrexone, oral methadone or sublingual buprenorphineErin Kelty, David Joyce, Gary Hulse
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Drugs|May 25, 2017
A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed NeonatesErin Kelty, Gary Hulse
Drugs|May 25, 2017
A Retrospective Cohort Study of Obstetric Outcomes in Opioid-Dependent Women Treated with Implant Naltrexone, Oral Methadone or Sublingual Buprenorphine, and Non-Dependent ControlsErin Kelty, Gary Hulse
The American Journal on Addictions|November 17, 2017
A retrospective cohort study of the health of children prenatally exposed to methadone, buprenorphine or naltrexone compared with non-exposed control childrenErin Kelty, Gary Hulse
The International Journal on Drug Policy|June 14, 2017
Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexoneErin Kelty, Gary Hulse
Addiction (Abingdon, England)|April 11, 2012
Examination of mortality rates in a retrospective cohort of patients treated with oral or implant naltrexone for problematic opiate useErin Kelty, Gary Hulse
Journal of Public Health (Oxford, England)|June 8, 2017
Morbidity and mortality in opioid dependent patients after entering an opioid pharmacotherapy compared with a cohort of non-dependent controlsErin Kelty, Gary Hulse
Journal of Psychopharmacology (Oxford, England)|January 11, 2021
Pharmacological uses of flumazenil in benzodiazepine use disorders: a systematic review of limited dataAlexander T Gallo, Gary Hulse
Clinical Trials (London, England)|December 18, 2012
Assessing the usefulness of health data linkage in obtaining adverse event data in a randomised controlled trial of oral and implant naltrexone in the treatment of heroin dependenceErin Kelty, Hanh Ngo, Gary Hulse
The American Journal of Drug and Alcohol Abuse|December 21, 2019
A comparison of blood toxicology in fatalities involving alcohol and other drugs in patients with an opioid use disorder treated with methadone, buprenorphine, and implant naltrexoneErin Kelty, Gary Hulse, David Joyce
The American Journal of Drug and Alcohol Abuse|March 9, 2019
A retrospective cohort study of mortality rates in patients with an opioid use disorder treated with implant naltrexone, oral methadone or sublingual buprenorphineErin Kelty, David Joyce, Gary Hulse
Pageof 5